beta blocker: be used during perioperative period

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be used during perioperative period 1.00
be used during period 0.76
be contraindicated in pulmonary edema 0.75
be contraindicated in vascular disease 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.61
Plausible(beta blocker, be used during perioperative period) ⋁
Evidence: 0.77
¬ Salient(beta blocker, be used during perioperative period)

Similarity expansion

0.56
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.75
Evidence: 0.82
Remarkable(beta blocker, be used during perioperative period) ⋁
Evidence: 0.75
¬ Remarkable(beta blocker, be contraindicated in pulmonary edema)
0.54
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.75
Evidence: 0.77
Salient(beta blocker, be used during perioperative period) ⋁
Evidence: 0.74
¬ Salient(beta blocker, be contraindicated in pulmonary edema)
0.49
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.75
Evidence: 0.61
Plausible(beta blocker, be used during perioperative period) ⋁
Evidence: 0.60
¬ Plausible(beta blocker, be contraindicated in pulmonary edema)
0.47
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.75
Evidence: 0.53
Typical(beta blocker, be used during perioperative period) ⋁
Evidence: 0.58
¬ Typical(beta blocker, be contraindicated in pulmonary edema)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.77
Salient(beta blocker, be used during perioperative period) ⋁
Evidence: 0.53
¬ Typical(beta blocker, be used during perioperative period) ⋁
Evidence: 0.82
¬ Remarkable(beta blocker, be used during perioperative period)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.61
Plausible(beta blocker, be used during perioperative period) ⋁
Evidence: 0.53
¬ Typical(beta blocker, be used during perioperative period)